vimco ενέσιμο γαλάκτωμα για προβατίνες και θηλυκές αίγες
laboratorios hipra s.a. - inactivated staphylococcus aureus strain sp140 - emulsion for injection - vaccine - ewes goats
treosulfan/tillomed pd.sol.inf 5g
laboratorios tillomed spain s.l.u., spain calle marcelo spinola 8, planta 1, puerta f, 28016 madrid - treosulfan - pd.sol.inf (ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 5g - treosulfan 5g - treosulfan
inmeva, ενέσιμο εναιώρημα
laboratorios hipra s.a. - Αδρανοποιημένο Χλαμύδια abortus στέλεχος a22 Αδρανοποιημένο salmonella enterica subsp. enterica serovar abortusovis στέλεχος sao - suspension for injection - vaccine - sheep
icthiovac vr/pd, ενέσιμο γαλάκτωμα
laboratorios hipra s.a. - inactivated photobacterium damselae υποείδ. piscicida di 21 rps≥60%, inactivated listonella anguillarum serotype 01 rps≥75%, inactivated listonella anguillarum serotype 02α, rps≥75%, inactivated listonella anguillarum serotype 02β rps≥75% - emulsion for injection - vaccine - sea bass
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - Χοίροι - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.
viaxal® gra.sachet 25mg/sachet
laboratorios menarini sa, espana c./alfonso xii, 587, e 08918 badalona (barcelona) - dexketoprofen trometamol - gra.sachet (ΚΟΚΚΙΑ ΣΕ ΦΑΚΕΛΙΣΚΟ) - 25mg/sachet - dexketoprofen trometamol 36,91mg - dexketoprofen
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - Χοίροι - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.
sildenafil/bausch health f.c.tab 100mg/tab
bausch health ireland limited, ireland 3013 lake drive, d24ppt3 dublin 24 - sildenafil citrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 100mg/tab - sildenafil citrate 100mg - sildenafil
methylphenidate/rubio 5mg/tab tab
laboratorios rubio s.a. barcelona, spain - methylphenidate - ΔΙΣΚΙΟ - 5mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
methylphenidate/rubio 10mg/tab tab
laboratorios rubio s.a. barcelona, spain - methylphenidate - ΔΙΣΚΙΟ - 10mg/tab